Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception

N Engl J Med. 2018 Sep 6;379(10):979-981. doi: 10.1056/NEJMc1807653. Epub 2018 Jul 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Botswana / epidemiology
  • Drug Therapy, Combination
  • Female
  • HIV Infections / drug therapy
  • HIV Integrase Inhibitors / adverse effects*
  • Heterocyclic Compounds, 3-Ring / adverse effects*
  • Humans
  • Neural Tube Defects / chemically induced*
  • Neural Tube Defects / epidemiology
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Prevalence

Substances

  • Anti-Retroviral Agents
  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • dolutegravir